Novartis Gains Rights To Debio 025

Novartis has gained rights to develop and market Debio 025 (alisporivir), a potential first-in-class antiviral agent, currently in phase IIb development for the treatment of hepatitis C. Debio 025 has...

Published: 09-Feb-2010

FDA Postpones Review Meeting For Pixantrone

FDA has informed Cell Therapeutics (CTI) that due to severe weather conditions in the Washington, DC area, it is postponing the Oncologic Drugs Advisory Committee (ODAC) meeting that was to be held on...

Published: 09-Feb-2010

FDA Accepts Psyadon IND In LND Trial

Psyadon Pharmaceuticals has announced that the FDA has accepted its Investigational New Drug Application (IND) to study ecopipam in patients with lesch-nyhan disease (LND). ...

Published: 09-Feb-2010

Amgen's Denosumab Demonstrates Superiority Over Zometa

Amgen has reported that a pivotal phase 3, head-to-head trial evaluating Denosumab versus Zometa (zoledronic acid) in the treatment of bone metastases in 1,901 men with advanced prostate cancer, has m...

Published: 09-Feb-2010

Lupin Receives FDA Approval For Amlodipine/Benazepril Capsules

Lupin has received final approval for Amlodipine/ Benazepril 2.5mg/10mg, 5mg/10mg, 5mg/20mg and 10mg/20mg capsules. Commercial shipment of the product has already initiated. ...

Published: 08-Feb-2010

Addex' New Drug Shows Analgesic Effects In Three Pain Models

Switzerland-based Addex Pharmaceuticals has revealed that in a clinical trial involving its ADX71943, the compound showed analgesic effects on pain. The trial involved three preclinical models of pain...

Published: 08-Feb-2010

Lipoxen Gets European Patent For Polysialylated G-CSF StimuXen Technology

Lipoxen, a bio-pharmaceutical company with expertise in differentiated biologicals, vaccines and siRNA delivery, has got patent for Polysialylated G-CSF StimuXen technology in UK, Germany, France, Spa...

Published: 08-Feb-2010

Novavax Terminates Influenza Vaccine Collaboration Negotiations With ROVI

Novavax has decided to terminate its negotiations with ROVI Pharmaceuticals, relating to previously announced collaboration. The collaboration was aimed at developing Novavax's virus-like-particle (VL...

Published: 08-Feb-2010

LPC Pharma To Outsource Pharmacovigilance/Drug Safety To APCER

APCER Pharma has announced that LPC Pharma is outsourcing its pharmacovigilance/drug safety operations to the company. ...

Published: 08-Feb-2010

European Commission Approves Almirall's BPH Drug

Almirall has reported that the European Commission has granted a marketing authorisation for Silodosin. The product will be marketed in Spain by Almirall and Recordati under the trademarks, Silodyx an...

Published: 08-Feb-2010

Actavis To Expand Iceland Facility

Actavis has said that it will be expanding its manufacturing site in Iceland, whereby increasing capacity at the site by 50%. With this decision, the company also intends to create 50 new jobs. ...

Published: 08-Feb-2010

SciClone, Sigma-Tau Updates On Zadaxin Trial

SciClone Pharmaceuticals and its partner, Sigma-Tau have announced additional topline results of a clinical study. The trial evaluated the potential of Zadaxin (thymalfasin) to enhance immune response...

Published: 08-Feb-2010

more news...